A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants
Clinical trial NCT03403348 · COMPLETED
Trial details
- NCT number
- NCT03403348
- Sponsor
- Janssen BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2019-11-24
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.